Cargando…
Comparison of in-vitro and in-vivo response to fetal hemoglobin production and γ-mRNA expression by hydroxyurea in Hemoglobinopathies
BACKGROUND: Hydroxyurea, which induces Fetal hemoglobin (HbF) synthesis, is the only drug widely used in different hemoglobinopathies; however, the response is very variable. We compared the efficacy of hydroxyurea in-vitro in erythroid cultures and in-vivo in the same patients with different hemogl...
Autores principales: | Italia, Khushnooma, Jijina, Farah, Merchant, Rashid, Swaminathan, Suchitra, Nadkarni, Anita, Gupta, Maya, Ghosh, Kanjaksha, Colah, Roshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758735/ https://www.ncbi.nlm.nih.gov/pubmed/24019630 |
Ejemplares similares
-
Hydroxyurea Could Be a Good Clinically Relevant Iron Chelator
por: Italia, Khushnooma, et al.
Publicado: (2013) -
FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India
por: Swaminathan, Suchitra, et al.
Publicado: (2014) -
The Fc Receptor Polymorphisms and Expression of Neutrophil Activation Markers in Patients with Sickle Cell Disease from Western India
por: Kangne, Harshada K., et al.
Publicado: (2013) -
Guidelines for screening, diagnosis and management of hemoglobinopathies
por: Ghosh, Kanjaksha, et al.
Publicado: (2014) -
Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients
por: Dabke, Pooja, et al.
Publicado: (2013)